Active Ingredient: DAPTOMYCIN
Proprietary Name: DAPTOMYCIN
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 350MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209949
Product Number: 001
Approval Date: Oct 20, 2017
Applicant Holder Full Name: XELLIA PHARMACEUTICALS APS
Marketing Status:
Prescription
Patent and Exclusivity Information